2000
DOI: 10.1128/jvi.74.9.4244-4252.2000
|View full text |Cite
|
Sign up to set email alerts
|

A Single Intramuscular Injection of Recombinant Plasmid DNA Induces Protective Immunity and Prevents Japanese Encephalitis in Mice

Abstract: Plasmid vectors containing Japanese encephalitis virus (JEV) premembrane (prM) and envelope (E) genes were constructed that expressed prM and E proteins under the control of a cytomegalovirus immediate-early gene promoter. COS-1 cells transformed with this plasmid vector (JE-4B clone) secreted JEV-specific extracellular particles (EPs) into the culture media. Groups of outbred ICR mice were given one or two doses of recombinant plasmid DNA or two doses of the commercial vaccine JEVAX. All mice that received on… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
114
0

Year Published

2003
2003
2013
2013

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 114 publications
(117 citation statements)
references
References 51 publications
3
114
0
Order By: Relevance
“…This was not due to inadequate dosing, as a ten-fold higher amount of DNA plasmid did not substantially alter the antibody response. Consistent with our findings, relatively low levels of specific and neutralizing antibodies were generated after immunization of mice and monkeys with DNA plasmid vaccines for dengue and Japanese encephalitis viruses [48,50]. One caveat to our analysis is that the DNA plasmid vaccine, despite having a less robust antibody response, still protected mice against IP challenge with the New York strain of WNV.…”
Section: Discussionsupporting
confidence: 76%
See 1 more Smart Citation
“…This was not due to inadequate dosing, as a ten-fold higher amount of DNA plasmid did not substantially alter the antibody response. Consistent with our findings, relatively low levels of specific and neutralizing antibodies were generated after immunization of mice and monkeys with DNA plasmid vaccines for dengue and Japanese encephalitis viruses [48,50]. One caveat to our analysis is that the DNA plasmid vaccine, despite having a less robust antibody response, still protected mice against IP challenge with the New York strain of WNV.…”
Section: Discussionsupporting
confidence: 76%
“…DNA plasmid vaccines, which propagate within cells, should elicit robust and durable antibody and cellular immunity and carry no risk of infection. DNA plasmid based vaccines have protected animals against challenge with Japanese encephalitis [48,49], dengue [50], Saint Louis encephalitis [51], Murray Valley encephalitis [52], tick-borne encephalitis [53], and WNV [15,18,21]. However, most of these studies did not provide a detailed comparison of potency of immune responses compared to other vaccine modalities.…”
Section: Discussionmentioning
confidence: 99%
“…Potential cleavage sites for ROCV polyprotein were primarily determined, according to the proteolytic processing cascade pattern for the flavivirus ORFs developed by Rice & Strauss (1990). The highest cleavage potential scores obtained by SignalP-NN computer program (http://www.cbs.dtu.dk/services/) (Chang et al, 2000) were used for determining the sites cleaved by the host cell-encoded signallase. Predicted glycosylation and cysteine residue sites were determined using the NetNGlyc (v.1.0) (http:// www.cbs.dtu.dk/services/) and Protean (v. 5.03) of the LaserGene program (DNA Star), respectively.…”
Section: Methodsmentioning
confidence: 99%
“…DNA and live vaccines have the capacity to stimulate adaptive cellular immunity. The potential of DNA vaccination for WNV has been demonstrated in mouse and horse infection models [25,29]. In this strategy, a c-DNA copy of the prM/E coding region of WNV is inserted into the mammalian expression plasmid vector pCBJESS, a derivative of pCBamp modified to contain the JE virus signal sequence.…”
Section: Immune Responses and Vaccinesmentioning
confidence: 99%